Split Epimerase Engineering for Alkaloid Production Yield
Solution Overview
Problem
Current methods for producing benzylisoquinoline alkaloids in engineered host cells are limited by the efficiency of epimerization processes, particularly in converting (S)-1-benzylisoquinoline alkaloids to (R)-1-benzylisoquinoline alkaloids, as existing epimerases do not effectively enhance production yields.
Innovation Solution
The use of engineered split epimerases, comprising separate oxidase and reductase enzymes, which are derived from different parent enzymes or modified to increase activity, enhances the conversion of (S)-1-benzylisoquinoline alkaloids to (R)-1-benzylisoquinoline alkaloids in engineered host cells, improving production efficiency compared to wild-type epimerases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If wild-type epimerases are used for converting (S)-1-benzylisoquinoline alkaloids to (R)-1-benzylisoquinoline alkaloids, then the epimerization process can proceed, but the production yield and efficiency are limited
Solution Approach 1:
The patent divides the epimerase into two separate functional components: an oxidase portion and a reductase portion. These can be expressed as separate proteins or as a fusion protein, allowing independent optimization of each component's activity. This segmentation enables the oxidase to perform oxidative epimerization while the reductase performs reductive epimerization, with each component contributing to overall productivity without limiting the other.
Solution Approach 2:
The patent employs protein engineering techniques to modify amino acid sequences of the oxidase and reductase portions, changing their catalytic parameters to enhance activity. Specific mutations are introduced to improve substrate binding affinity, catalytic rate, or stability, thereby increasing the overall effectiveness and production yield of the epimerization process.
2Productivity
If engineered fused epimerases with modified oxidase portions are used, then epimerase activity is increased, but the complexity of enzyme engineering increases
Solution Approach 1:
By segmenting the epimerase into oxidase and reductase portions, the patent simplifies the engineering approach. Each portion can be independently cloned, mutated, and optimized using standard molecular biology techniques. This modular design reduces the complexity compared to engineering a single large epimerase protein, as each component can be developed and tested separately before combination.
Solution Approach 2:
The oxidase and reductase portions are designed to be universally applicable to various benzylisoquinoline alkaloid substrates. The engineered portions maintain broad substrate specificity while enhancing catalytic activity, allowing the same engineered components to be used across different alkaloid production pathways without requiring separate engineering for each substrate.
3Productivity
If the epimerization process is optimized for higher conversion efficiency, then production yields improve, but the process time and operational complexity increase
Solution Approach 1:
The patent employs a continuous epimerization process where the engineered epimerase (either fused or split) operates continuously to convert (S)-1-benzylisoquinoline alkaloids to (R)-1-benzylisoquinoline alkaloids. The enzyme system maintains high catalytic activity throughout the process without requiring interruption for reagent addition or process adjustment, thereby achieving high conversion efficiency without proportionally increasing process time.
Solution Approach 2:
The engineered epimerase system is designed to be self-sufficient, with the oxidase and reductase portions working in tandem without requiring external cofactor supplementation or process intervention. The enzyme system autonomously performs both oxidation and reduction steps needed for epimerization, eliminating the need for additional process steps and reducing operational complexity while maintaining high conversion efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases the production of diverse alkaloid products by efficiently converting (S)-1-benzylisoquinoline alkaloids to (R)-1-benzylisoquinoline alkaloids, leading to higher yields of alkaloid products such as reticuline, thebaine, and other morphinan derivatives in engineered host cells.
Implementation Method 1
engineered fused epimerases may have one or more modifications to an oxidase portion of the engineered fused epimerase
Implementation Method 2
an engineered fused enzyme may have an oxidase enzyme portion and a reductase enzyme portion
Data Source
AI summary
The present disclosure provides systems and methods for increasing production of an alkaloid product through the epimerization of a (S)-1-benzylisoquinoline alkaloid to a (R)-1-benyzlisoquinoline alkaloid via an engineered epimerase in an engineered host cell. A (S)-1-benzylisoquinoline alkaloid is contacted with said engineered epimerase. Contacting said (S)-1-benzylisoquinoline alkaloid with said engineered epimerase converts said (S)-1-benzylisoquinoline alkaloid to said (R)-1-benzylisoquinoline alkaloid.